» Articles » PMID: 24418231

Simultaneous Quantification of 20 Synthetic Cannabinoids and 21 Metabolites, and Semi-quantification of 12 Alkyl Hydroxy Metabolites in Human Urine by Liquid Chromatography-tandem Mass Spectrometry

Overview
Journal J Chromatogr A
Publisher Elsevier
Specialty Chemistry
Date 2014 Jan 15
PMID 24418231
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Clandestine laboratories constantly produce new synthetic cannabinoids to circumvent legislative efforts, complicating toxicological analysis. No extensive synthetic cannabinoid quantitative urinary methods are reported in the literature. We developed and validated a liquid chromatography-tandem mass spectrometric (LC-MS/MS) method for simultaneously quantifying JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-250, JWH-398, RCS-4, AM-2201, MAM-2201, UR-144, CP 47,497-C7, CP 47,497-C8 and their metabolites, and JWH-203, AM-694, RCS-8, XLR-11 and HU-210 parent compounds in urine. Non-chromatographically resolved alkyl hydroxy metabolite isomers were considered semi-quantitative. β-Glucuronidase hydrolyzed urine was extracted with 1ml Biotage SLE+ columns. Specimens were reconstituted in 150μL mobile phase consisting of 50% A (0.01% formic acid in water) and 50% B (0.01% formic acid in 50:50 methanol:acetonitrile). 4 and 25μL injections were performed to acquire data in positive and negative ionization modes, respectively. The LC-MS/MS instrument consisted of a Shimadzu UFLCxr system and an ABSciex 5500 Qtrap mass spectrometer with an electrospray source. Gradient chromatographic separation was achieved utilizing a Restek Ultra Biphenyl column with a 0.5ml/min flow rate and an overall run time of 19.5 and 11.4min for positive and negative mode methods, respectively. Quantification was by multiple reaction monitoring with CP 47,497 compounds and HU-210 ionized via negative polarity; all other analytes were acquired in positive mode. Lower and upper limits of linearity were 0.1-1.0 and 50-100μg/l (r(2)>0.994). Validation parameters were evaluated at three concentrations spanning linear dynamic ranges. Inter-day analytical recovery (bias) and imprecision (N=20) were 88.3-112.2% and 4.3-13.5% coefficient of variation, respectively. Extraction efficiencies and matrix effect (N=10) were 44-110 and -73 to 52%, respectively. We present a novel LC-MS/MS method for simultaneously quantifying 20 synthetic cannabinoids and 21 metabolites, and semi-quantifying 12 alkyl hydroxy metabolites in urine.

Citing Articles

A critical review of workplace drug testing methods for old and new psychoactive substances: Gaps, advances, and perspectives.

Al-Asmari A Saudi Pharm J. 2024; 32(5):102065.

PMID: 38645754 PMC: 11031841. DOI: 10.1016/j.jsps.2024.102065.


Long-term stability of 24 synthetic cannabinoid metabolites spiked into whole blood and urine for up to 168 days, and the comparable study for the 6 metabolites in non-spiked real case specimens stored for  1-5 years.

Minakata K, Hasegawa K, Nozawa H, Yamagishi I, Miyoshi N, Suzuki M Forensic Toxicol. 2022; 40(2):289-301.

PMID: 36454405 DOI: 10.1007/s11419-022-00613-1.


Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models.

Dahm P, Thomas A, Rothschild M, Thevis M, Mercer-Chalmers-Bender K Forensic Toxicol. 2022; 40(2):244-262.

PMID: 36454402 PMC: 9715525. DOI: 10.1007/s11419-021-00606-6.


Rapid Simultaneous Determination of Three Synthetic Cannabinoids in Urine and Plasma of Rats Using Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry.

Ke X, Tian Y, He D, Mu P, Wan X, Zhang L Toxics. 2022; 10(10).

PMID: 36287899 PMC: 9611048. DOI: 10.3390/toxics10100619.


Dispersive liquid-liquid microextraction, an effective tool for the determination of synthetic cannabinoids in oral fluid by liquid chromatography-tandem mass spectrometry.

Tomai P, Gentili A, Curini R, Gottardo R, Tagliaro F, Fanali S J Pharm Anal. 2021; 11(3):292-298.

PMID: 34277117 PMC: 8264461. DOI: 10.1016/j.jpha.2020.11.004.


References
1.
Wu A, Gerona R, Armenian P, French D, Petrie M, Lynch K . Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology. Clin Toxicol (Phila). 2012; 50(8):733-42. DOI: 10.3109/15563650.2012.713108. View

2.
ElSohly M, Gul W, ElSohly K, Murphy T, Madgula V, Khan S . Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites. J Anal Toxicol. 2011; 35(7):487-95. DOI: 10.1093/anatox/35.7.487. View

3.
Beuck S, Moller I, Thomas A, Klose A, Schlorer N, Schanzer W . Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing. Anal Bioanal Chem. 2011; 401(2):493-505. DOI: 10.1007/s00216-011-4931-5. View

4.
Wissenbach D, Meyer M, Remane D, Philipp A, Weber A, Maurer H . Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept. Anal Bioanal Chem. 2011; 400(10):3481-9. DOI: 10.1007/s00216-011-5032-1. View

5.
Young A, Schwarz E, Medina G, Obafemi A, Feng S, Kane C . Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation. Am J Emerg Med. 2011; 30(7):1320.e5-7. DOI: 10.1016/j.ajem.2011.05.013. View